BURLINGTON, Mass. and JERUSALEM, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its participation in the Annual Meeting of the Clinical TMS Society's (CTMSS) from May 4-6 and the Annual Meeting of the American Psychiatric Association (APA) from May 20-24. The Company will present posters at both meetings focusing on BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS™) for treatment-resistant depression. "It has been fantastic to see the growing level of interest clinical psychiatrists and clinical researchers have in Deep TMS technology.